4DX4DMedical Limited

4DX Stock Price, Valuation & Chart | 4DMedical Limited

Compare

$4.090+0.01 (+0.25%)

At close · 16 Oct 2026, 05:19 am

Sector: Healthcare Industry: Medical - Devices Website

Overview Financials Dividends Ratios

4DX Historical price chart

4DX Key Stats

Market Capitalization2.46B

PE Ratio-10.35

EPS-0.4

Trading Volume3.06M

Today's High/Low4.2/3.96

Dividend Yield0.00

52 Week High/Low7.55/1.4

Shares Outstanding602.03M

4DX Financial Statement

4DX Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 3 analysts giving stock ratings to 4DX in the past 3 months.

4DX Analysis & performance metrics

4DX Company profile

4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology.…

4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a…

4DX Management team

Name

Position

Naomi Lawrie

Company Secretary & General Counsel

John Andrew Livingston BAppSci, GradCertBus, GradDipHScCTO

Strategic Advisor & Executive Director

Andreas Fouras M.A.I.C.D., Ph.D.CEO

Founder, MD, Chief Executive Officer & Director

Aidan Jamison B.E., Ph.D.

Senior Vice President of Engineering

Greg T. Mogel M.D.

Chief Medical Officer

David Hannes B.S., M.B.A.

Senior Vice President of Global Business Development

Simon GloverCFO

Chief Financial Officer

Matt Tucker

Chief Commercial Officer

Name

Position

Naomi Lawrie

Company Secretary & General Counsel

John Andrew Livingston BAppSci, GradCertBus, GradDipHScCTO

Strategic Advisor & Executive Director

Andreas Fouras M.A.I.C.D., Ph.D.CEO

Founder, MD, Chief Executive Officer & Director

Aidan Jamison B.E., Ph.D.

Senior Vice President of Engineering

Greg T. Mogel M.D.

Chief Medical Officer

David Hannes B.S., M.B.A.

Senior Vice President of Global Business Development

Simon GloverCFO

Chief Financial Officer

Matt Tucker

Chief Commercial Officer

Management Team

Naomi Lawrie

Company Secretary & General Counsel

John Andrew Livingston BAppSci, GradCertBus, GradDipHScCTO

Strategic Advisor & Executive Director

Andreas Fouras M.A.I.C.D., Ph.D.CEO

Founder, MD, Chief Executive Officer & Director

Aidan Jamison B.E., Ph.D.

Senior Vice President of Engineering

Greg T. Mogel M.D.

Chief Medical Officer

David Hannes B.S., M.B.A.

Senior Vice President of Global Business Development

Simon GloverCFO

Chief Financial Officer

Matt Tucker

Chief Commercial Officer

Management

Naomi Lawrie

Company Secretary & General Counsel

John Andrew Livingston BAppSci, GradCertBus, GradDipHScCTO

Strategic Advisor & Executive Director

Andreas Fouras M.A.I.C.D., Ph.D.CEO

Founder, MD, Chief Executive Officer & Director

Aidan Jamison B.E., Ph.D.

Senior Vice President of Engineering

Greg T. Mogel M.D.

Chief Medical Officer

David Hannes B.S., M.B.A.

Senior Vice President of Global Business Development

Simon GloverCFO

Chief Financial Officer

Matt Tucker

Chief Commercial Officer

Total 8 executives

4DX Frequently asked questions

What is 4DMedical Limited (4DX) Stock Price?

Current stock price of 4DMedical Limited (4DX) stock is $4.090. The stock price is +0.25% higher in the session. The intraday range can be seen from this page. Volume of 4DMedical Limited (4DX) stock is 3.06M.

Last updated at 16 Oct 2026, 05:19 am.

Why is the 4DMedical Limited (4DX) stock price going up or down today?

The stock price of 4DMedical Limited (4DX) can change with earnings, company news, and overall market sentiment. 4DMedical Limited operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the 4DMedical Limited stock expensive at its current price?

Whether 4DMedical Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for 4DX on this page is -10.35. EPS on this page is -0.40. Compare those figures with peers and growth expectations before deciding if the current 4DMedical Limited price is justified.

How has the stock price of 4DMedical Limited (4DX) performed historically?

Historical performance for 4DMedical Limited (4DX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how 4DX reacted to past earnings and market events.

Should I buy 4DMedical Limited (4DX) stock, at this price?

Buying 4DMedical Limited (4DX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.